标题
Generation and validation of structurally defined antibody–siRNA conjugates
作者
关键词
-
出版物
NUCLEIC ACIDS RESEARCH
Volume 48, Issue 10, Pages 5281-5293
出版商
Oxford University Press (OUP)
发表日期
2020-04-17
DOI
10.1093/nar/gkaa286
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antibody–drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study
- (2019) Suzanne Trudel et al. Blood Cancer Journal
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- Site Selective Antibody-Oligonucleotide Conjugation via Microbial Transglutaminase
- (2019) Ian J. Huggins et al. MOLECULES
- Facile Synthesis, Geometry, and 2′-Substituent-Dependent in Vivo Activity of 5′-(E)- and 5′-(Z)-Vinylphosphonate-Modified siRNA Conjugates
- (2018) Rubina Giare Parmar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates
- (2018) Donald J. Foster et al. MOLECULAR THERAPY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial
- (2018) Suzanne Trudel et al. LANCET ONCOLOGY
- Antibodies to watch in 2019
- (2018) Hélène Kaplon et al. mAbs
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
- (2017) Jayaprakash K. Nair et al. NUCLEIC ACIDS RESEARCH
- Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates
- (2017) Alex R. Nanna et al. Nature Communications
- 5′-(E)-Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA-GalNAc Conjugates
- (2016) Rubina Parmar et al. CHEMBIOCHEM
- Immune Therapies in Multiple Myeloma
- (2016) Shaji K. Kumar et al. CLINICAL CANCER RESEARCH
- Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles
- (2016) Tsukasa Sugo et al. JOURNAL OF CONTROLLED RELEASE
- Structural Analysis of Human Argonaute-2 Bound to a Modified siRNA Guide
- (2016) Nicole T. Schirle et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- CD4-Induced Antibodies Promote Association of the HIV-1 Envelope Glycoprotein with CD4-Binding Site Antibodies
- (2016) Matthew R. Gardner et al. JOURNAL OF VIROLOGY
- Role of Wnt/β-catenin pathway in inducing autophagy and apoptosis in multiple myeloma cells
- (2016) Nan Su et al. Oncology Letters
- Antibody-Mediated Delivery of Anti-KRAS-siRNA In Vivo Overcomes Therapy Resistance in Colon Cancer
- (2015) S. Baumer et al. CLINICAL CANCER RESEARCH
- Antibody-coupled siRNA as an efficient method for in vivo mRNA knockdown
- (2015) Nicole Bäumer et al. Nature Protocols
- Clinical experiences with systemically administered siRNA-based therapeutics in cancer
- (2015) Jonathan E. Zuckerman et al. NATURE REVIEWS DRUG DISCOVERY
- Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma
- (2014) Y.-T. Tai et al. BLOOD
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates
- (2014) Trinna L. Cuellar et al. NUCLEIC ACIDS RESEARCH
- Site-Specific Antibody–Polymer Conjugates for siRNA Delivery
- (2013) Hua Lu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
- (2012) Muthusamy Jayaraman et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma
- (2011) Jin Lv et al. MEDICAL ONCOLOGY
- Expanding the Concept of Chemically Programmable Antibodies to RNA Aptamers: Chemically Programmed Biotherapeutics
- (2010) Ulrich Wuellner et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Phase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer
- (2010) Ian E. Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Rational design of cationic lipids for siRNA delivery
- (2010) Sean C Semple et al. NATURE BIOTECHNOLOGY
- The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
- (2009) H. Ikeda et al. CLINICAL CANCER RESEARCH
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice
- (2008) Priti Kumar et al. CELL
- Antibody-Mediated Targeting of siRNA via the Human Insulin Receptor Using Avidin−Biotin Technology
- (2008) Chun-Fang Xia et al. MOLECULAR PHARMACEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now